354 Bibliografia [1] Stephanie J Lee, Georgia Vogelsang, Mary ED Flowers. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215-233. doi: 10.1053/bbmt.2003.50026. [2] George B McDonald. Hepatobiliary complications of hematopoietic cell transplantation, 40 years on. Hepatology 2010; 51: 1450-1460. doi: 10.1002/hep.30222. [3] H M Shulman, K M Sullivan, P L Weiden, G B McDonald, G E Striker, G E Sale et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217. doi: 10.1016/0002-9343(80)90380-0. [4] Howard M Shulman, Diana M Cardona, Joel K Greenson, Sangeeta Hingorani, Thomas Horn, Elisabeth Huber et al. NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. The 2014 Pathology Working Group Report, Biol Blood Marrow Transplant 2015 Apr;21(4):589603. doi: 10.1016/j.bbmt.2014.12.031. [5] G R Hill, J L Ferrara. The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood 2000; 95: 2754-2759 [6] S I Strasser, H M Shulman, M E Flowers, R Reddy, D A Margolis, M Prumbaum et al. Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis. Hepatology 2000; 32: 1265 – 1271 doi: 10.1053/jhep.2000.20067. [7] Noelle V Frey, David L Porter. Graft-versus-host disease after donor leukocyte infusions: presentation and management. Best Pract Res Clin Haematol 2008 Jun;21(2):205-22 doi: 10.1016/j. beha.2008.02.007. [8] Görgün Akpek, John K Boitnott, Linda A Lee, Jason P Hallick, Michael Torbenson, David A Jacobsohn et al. Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion. Blood 2002 Dec 1;100(12):3903-7. doi: 10.1182/blood-2002-03-0857. [9] Madan Jagasia, Mukta Arora, Mary E. D. Flowers, Nelson J. Chao, Philip L. McCarthy, Corey S. Cutler et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood 2012; 119 (1): 296–307. doi: 10.1182/blood-2011-06-364265. [10] M D Saunders, H M Shulman, C S Murakami, T R Chauncey, W I Bensinger, G B McDonald. Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation. Am J Surg Pathol 2000 Jul;24(7):1004-8. doi: 10.1097/00000478-200007000-00012. [11] Elvire Beleoken, Rodolphe Sobesky, Jean-Pierre Le Caer, François Le Naour, Mylène Sebagh, Nicolas Moniaux et al. Immunoproteomic analysis of potentially severe non-graft-versushost disease hepatitis after allogenic bone marrow transplantation. Hepatology 2013; 57:689-699. doi: 10.1002/hep.26024. [12] Judith Stift, Hideo A Baba, Elisabeth Huber, Birgit Federmann, Hans-Peter Fischer, Annette Schmitt-Graeff et al. Consensus on the histopathological evaluation of liver biopsies from patients following allogeneic hematopoietic cell transplantation. Virchows Arch 2014; 464:175–190. doi: 10.1007/s00428-013-15288. [13] A R Crawford, X Z Lin, J M Crawford. The normal adult human liver biopsy: a quantitative reference standard. Hepatology 1998; 28: 323-331. doi: 10.1002/hep.510280206. [14] Quaglia A, Duarte R, Patch D, Ngianga-Bakwin K, Dhillon AP. Histopathology of graft versus host disease of the liver. Histopathology. 2007;50:727-738. doi: 10.1111/j.1365-2559.2007.02679.x. [15] A Theodossi, A M Skene, B Portmann, R P Knill-Jones, R S Patrick, R A Tate et al. Observer variation in assessment of liver biopsies including analysis by kappa statistics. Gastroenterology 1980 Aug;79(2):232-41. [16] Zachary D. Goodman. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. Journal of Hepatology 2007; 47: 598–607. doi: 10.1016/j.jhep.2007.07.006. [17] H M Shulman, P Sharma, D Amos, L F Fenster, G B McDonald. A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation. Hepatology 1988; 8: 463-470. doi: 10.1002/hep.1840080305. [18] Tom Z. Liang, Stephen Dong, Mike Fang, Yuna Gong, George Yaghmour and Shefali Chopra. Hepatitic Variant of Graft vs-Host Disease, Prevalence and Comparison With Clinicopathologic Features of the Classic Variant. Am J Clin Pathol 2022;157:948-955. doi: 10.1093/ajcp/aqab215. [19] Ashley E Stueck, Thomas D Schiano, M Isabel Fiel. Development of a novel histologic diagnostic algorithm for hepatic graftversus-host disease. Development of a novel histologic diagnostic algorithm for hepatic graft-versus-host disease. Modern Pathology 2018; 31: 442-451. doi: 10.1038/modpathol.2017.151. [20] D J Stechschulte Jr, J L Fishback, A Emami, P Bhatia. Secondary biliary cirrhosis as a consequence of graft-versus-host disease. Gastroenterology 1990;98: :223-225. doi: 10.1016/00165085(90)91315-w. [21] Moreira RK, Chopp W, Washington MK. The concept of hepatic artery-bile duct parallelism in the diagnosis of ductopenia in liver biopsy samples. Am J Surg Pathol 2011; 35(3):392–403. doi: 10.1097/PAS.0b013e3182082ef6. [22] W Ekataksin, K Wake. Liver units in three dimensions: I. Organization of argyrophilic connective tissue skeleton in porcine liver with particular reference to the "compound hepatic lobule". Am J Anat 1991 Jun;191(2):113-53. doi: 10.1002/aja.1001910202. [23] Lefkowitch JH, Lobritto SJ, Brown RS Jr, et al. Ground-glass, polyglucosan-like hepatocellular inclusions: a “new” diagnostic entity. Gastroenterology. 2006;131(3):713–8. doi: 10.1053/j.gastro.2006.07.006. [24] Rammurti T Kamble 1, George B Selby, MarthaMims, Mohamed A Kharfan-Dabaja, Howard Ozer, James N George. Iron overload manifesting as apparent exacerbation of hepatic graft-versushost disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006 May;12(5):506-10. doi: 10.1016/j.bbmt.2006.01.004. [25] Marco Fiore, Marco Cascella, Sabrina Bimonte, Alberto Enrico Maraolo, Ivan Gentile, Vincenzo Schiavone, Maria Caterina Pace. Liver fungal infections: an overview of the etiology and epidemiology in patients affected or not affected by oncohematologic malignancies. Infection and Drug Resistance 2018:11 177–186. doi: 10.2147/IDR.S152473. [26] S Kommareddi, C R Abramowsky, G L Swinehart, L Hrabak. Nontuberculous mycobacterial infections: comparison of the fluorescent auramine-O and Ziehl-Neelsen techniques in tissue diagnosis. Hum Pathol 1984 Nov;15(11):1085-9. doi: 10.1016/s00468177(84)80253-1. [27] Filipe Vilas-Boas 1, Regina Gonçalves, Manuel Sobrinho
RkJQdWJsaXNoZXIy ODUzNzk5